Can Hypertension (HTN) cause Atrial Fibrillation (AF)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hypertension Can Cause Atrial Fibrillation

Yes, hypertension is a major cause of atrial fibrillation and contributes to up to 24% of incident atrial fibrillation cases. 1, 2 Hypertension leads to structural and electrical changes in the heart that create an ideal substrate for the development of AF.

Pathophysiological Mechanisms

Hypertension contributes to AF development through several mechanisms:

  1. Structural cardiac changes:

    • Left ventricular diastolic dysfunction
    • Left atrial overload and remodeling
    • Left ventricular hypertrophy (LVH) 1
  2. Electrical remodeling:

    • Abnormal expression of ion channels
    • Enhanced myocardial sodium vulnerability
    • Heterogeneity in intra-atrial conduction 1
  3. Neurohormonal activation:

    • Renin-angiotensin-aldosterone system (RAAS) activation
    • Sympathetic nervous system activation
    • Oxidative stress and inflammation 1, 3
  4. Hemodynamic effects:

    • Mechanical overload due to high blood pressure
    • Blunted nocturnal BP fall 1

Epidemiological Evidence

  • Hypertension is present in up to 80% of patients with AF, making it the most common comorbid condition 4
  • Even early forms of hypertension (prehypertension and aortic stiffness) are associated with increased risk of AF development 2
  • Hypertensive patients have up to 73% greater likelihood of developing AF 5

Clinical Implications and Management

  1. Stroke Risk Assessment:

    • Both AF and hypertension individually contribute to increased stroke risk
    • When both conditions are present together, stroke risk is further accentuated
    • Hypertension adds 1 point to the CHA₂DS₂-VASc score, affecting anticoagulation decisions 1
  2. Blood Pressure Control for AF Prevention and Management:

    • The European Society of Cardiology recommends blood pressure control (target <130/80 mmHg) as part of AF management 1
    • Treatment of hypertension with an ARB can be useful for prevention of recurrence of AF (Class IIa, Level B-R) 4
  3. Anticoagulation Management:

    • Uncontrolled hypertension increases bleeding risk in patients on oral anticoagulation therapy 4
    • Optimal BP control is crucial for both stroke and bleeding risk reduction in AF patients taking oral anticoagulants 4
    • Elevated BP (SBP ≥140 mmHg and/or DBP ≥90 mmHg) is associated with increased risk of stroke or systemic embolism (HR 1.53) and hemorrhagic stroke (HR 1.85) 4

Medication Considerations

  • RAAS Blockade: ACE inhibitors and ARBs may aid in LVH regression and potentially reduce AF burden 1
  • Avoid Electrolyte Disturbances: Thiazide diuretics can cause hypokalemia and hypomagnesemia, which may contribute to arrhythmias 1
  • Beta-Blockers: In patients with chronic aortic insufficiency, treatment of systolic hypertension with agents that do not slow the heart rate (i.e., avoid beta blockers) is reasonable 4

Prevention Strategies

  1. Risk Factor Modification:

    • Comprehensive approach including dietary modifications and prescribed exercise programs 2
    • Management should focus not only on blood pressure reduction but also on comprehensive cardiovascular risk factor modification 2
  2. Screening:

    • Systematic AF screening may be justified in all patients aged ≥65 years with hypertension 5
    • Most blood pressure monitors include algorithms to detect AF with high sensitivity (96%) and specificity (94%), though ECG confirmation is necessary 5

Key Pitfalls to Avoid

  1. Neglecting BP Control: Uncontrolled hypertension complicates AF management and diminishes the effectiveness of antiarrhythmic drugs, catheter ablation, and cardioversion 3

  2. Overlooking Nocturnal Hypertension: Blunted nocturnal fall in blood pressure increases AF occurrence 1

  3. Ignoring Electrolyte Monitoring: Regular monitoring is crucial to prevent hypokalemia and hypomagnesemia from antihypertensive therapy 1

  4. Underestimating the Impact of Prehypertension: Even early forms of hypertension increase AF risk and should be addressed 2

Hypertension is not just a comorbidity of AF but should be viewed as a key target for AF prediction and prevention. Effective blood pressure management can lower the risk of new-onset AF and reduce the incidence of recurrent AF, enhancing the success of rhythm control strategies 3, 6.

References

Guideline

Hypertension and Atrial Fibrillation Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hypertension and atrial fibrillation.

Journal of hypertension, 2022

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Atrial Fibrillation Detection and Management in Hypertension.

Hypertension (Dallas, Tex. : 1979), 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.